Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC

Lung cancer is one of the most common tumors and its treatment is still inefficient. In our previous work we proved that ciprofloxacin has a different influence on five cancer cell lines. Here, we aimed to compare the biological effect of ciprofloxacin on cell lines representing different responses...

Descripción completa

Detalles Bibliográficos
Autores principales: KLOSKOWSKI, TOMASZ, GURTOWSKA, NATALIA, OLKOWSKA, JOANNA, NOWAK, JAKUB MARCIN, ADAMOWICZ, JAN, TWORKIEWICZ, JAKUB, DĘBSKI, ROBERT, GRZANKA, ALINA, DREWA, TOMASZ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583647/
https://www.ncbi.nlm.nih.gov/pubmed/23042104
http://dx.doi.org/10.3892/ijo.2012.1653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583647/
https://www.ncbi.nlm.nih.gov/pubmed/23042104
http://dx.doi.org/10.3892/ijo.2012.1653

Ejemplares similares